Page 146 - Company Results

Q4 results today: IndiGo, ITC, and Fortis among 181 firms to post earnings

Company Q4 FY24 results today: ICRA, Rupa & Company, Page Industries, and Shilpa Medicare will also release their fourth quarter earnings report on May 23

Gland Pharma Q4 results: Net profit jumps over two-fold to Rs 192 crore

The company has reported a PAT of Rs 79 crore in the year-ago period, the Hyderabad-based drug firm said in a statement

Grasim Industries Q4 results: Net profit rises 15.5% to Rs 2,721.81 cr

Grasim Q4 results: The board recommended dividend of Rs 10 per equity share for FY24

Sun Pharma Q4 result: Profit up 33% over strong US, specialty sales

Firm guides for high single-digit top line, higher R&D spend in FY25; board approves appointment of Dilip Shanghvi as chairman

Paytm Q4 results: Loss widens to Rs 549.60 cr, revenue falls 2.6%

Company has 'transitioned' payment business from Paytm Payments Bank to other partner banks, says CEO

Sundram Fasteners Q4 results: Net profit up 5%, total revenue rises 2%

The consolidated earnings per share (EPS) for the quarter ended March 31, 2024, amounted to Rs 6.36, compared to Rs 6.01 in the corresponding period last year

Petronet LNG Q4 results: Net profit increases 20% to Rs 738 crore

For the entire 2023-24 fiscal (April 2023 to March 2024), Petronet reported highest-ever net profit of Rs 3,536 crore on the back of a 22 per cent growth in volume throughput

Ramco Cements Q4 results: Net profit falls over 20% to Rs 121 crore

Standalone net profit after tax fell over 20% year-on-year to Rs 121 crore ($14.5 million) during January-March, missing analysts' expectations of Rs 127 crore

Power Grid Corporation Q4 results: PAT dips marginally to Rs 4,166 crore

The company reported a consolidated net profit of Rs 4,322.87 crore in the quarter ended on March 31, 2023, a BSE filing showed

Shriram General Insurance Q4 results: PAT at Rs 121 cr, AUM at Rs 12,064 cr

The Gross Written Premium during the quarter under review was at Rs 876 crore up by 30 per cent over the same period of last financial year

Torrent Power Q4 results: PAT falls 4.2% to Rs 430 cr on higher fuel prices

Its revenue from operations rose 8.1% to Rs 6,529 crore, however, total expenses, led by fuel cost, rose nearly 10% to Rs 6,008 crore

Airtel Payments Bank's FY24 profit surges 60% to Rs 34.5 cr, revenue up 42%

Calling it the strongest quarter, the payments bank said it posted a 15 per cent sequential growth at Rs 539 crore in the March quarter

Strides Pharma Q4 Results: Posts net profit of Rs 10.44 cr, revenue up 5.6%

In the same quarter of the previous fiscal, Strides reported a loss of Rs 13.79 crore. Ebitda grew 4.61 per cent to Rs 204 crore

Jubilant FoodWorks Q4: Net profit jumps seven-fold to Rs 208 crore

Its revenue from operations rose 23.85 per cent to Rs 1,572.79 crore during the quarter. It was Rs 1,269.84 crore in the year-ago period, it added

Nykaa Q4 results: Net profit rises 187% to Rs 6.9 crore, revenue up 28%

Nykaa Q4FY24 results: FSN E-Commerce Ventures' revenue from operations grew by 28.1% to Rs 1,667.98 crore year-on-year

Sundaram Finance Holdings Q4 results: Net profit rises 173% to Rs 269.32 cr

The city-based company had recorded a consolidated net profit of Rs 98.62 crore during the corresponding quarter last year

TeamLease Q4 results: Net profit rises 14% on general staffing strength

The company said consolidated net profit came in at 274.8 million rupees ($3.30 million) for the three months ended March 31

Sun Pharma Q4 results: Net profit rises 34% to Rs 2,655 cr, revenue up 10%

Sun Pharma Q4FY24 results: The board of the company recommended a final dividend of Rs 5 per equity share of Re. 1 for the financial year 2023-24

Max Healthcare Institute Q4 results: PAT declines by 2.81% to Rs 311 crore

The company had posted a Profit After Tax (PAT) of Rs 320 crore in the same quarter of the previous fiscal, Max Healthcare Institute said in a statement

Strides Pharma Q4 results: Net profit declines 24% to Rs 10.44 crore

Consolidated total income in the quarter under review stood at Rs 1,070.49 crore as against Rs 1,013.49 crore in the same period a year ago, Strides Pharma Science said in a regulatory filing